JP Morgan Healthcare Conference: 7 trends to watch

Taking place this week in San Francisco, the annual JP Morgan Healthcare Conference has become the agenda-setting meeting for pharma and biotech. Andrew McConaghie reviews some key themes to watch out for at the conference and throughout 2016. Will the bubble burst?

The last few years have seen a strong resurgence in pharma and in biotech in particular, thanks to a wave of new innovation, plentiful funding for M&A and IPOs, and a sharp increase in the number of new drugs being approved.